Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000544231 | SCV000604130 | benign | Combined immunodeficiency due to LRBA deficiency | 2023-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000544231 | SCV000652633 | benign | Combined immunodeficiency due to LRBA deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000508516 | SCV000709547 | likely benign | not specified | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000659001 | SCV000780804 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | LRBA: BP4, BS2 |
Mayo Clinic Laboratories, |
RCV000544231 | SCV000782749 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000508516 | SCV002071117 | likely benign | not specified | 2020-03-02 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV000544231 | SCV002556590 | likely benign | Combined immunodeficiency due to LRBA deficiency | 2020-08-18 | criteria provided, single submitter | clinical testing | BS1, BP4 |
Center for Genomics, |
RCV000544231 | SCV003920156 | likely benign | Combined immunodeficiency due to LRBA deficiency | 2022-10-04 | criteria provided, single submitter | clinical testing | This variant has been reported in the literature in 1 individual with panuveitis (Li 2021 PMID:32707200). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.7% (543/67998) (https://gnomad.broadinstitute.org/variant/4-150321257-T-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:439869). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Prevention |
RCV003925503 | SCV004740896 | benign | LRBA-related disorder | 2019-05-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |